followed by Stage I in 2023 in the US. .Approved drugs for the treatment of Diffuse Large B-Cell Lymphoma include RITUXAN/MABTHERA (rituximab), YESCARTA (axicabtagene ciloleucel), KYMRIAH ...

In Canada, 1 in 12 people live with a rare disease, and for most people affected, the cost of treatment is unaffordable. Canadians deserve a health care system that provides timely access to quality ...

Today, the Governments of Canada and the province of Ontario signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over ...

Health CanadaIn Canada, 1 in 12 people live with a rare disease, and for most people affected, the cost of treatment ...

Approved drugs for the treatment of Diffuse Large B-Cell Lymphoma include RITUXAN/MABTHERA (rituximab), YESCARTA (axicabtagene ciloleucel), KYMRIAH (tisagenlecleucel), XPOVIO (selinexor), POLIVY ...

Approved drugs for the treatment of Diffuse Large B-Cell Lymphoma include RITUXAN/MABTHERA (rituximab), YESCARTA (axicabtagene ciloleucel), KYMRIAH (tisagenlecleucel), XPOVIO (selinexor), POLIVY ...

Yescarta (axicabtagene ciloleucel) has been approved as a treatment for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma ...

Ordspono (odronextamab) has been cleared by the European Commission to treat adults with relapsed/refractory follicular lymphoma (FL) or diffuse large B-cell lymphoma (DLBCL) who have progressed ...

Yescarta is a drug used to treat several forms of relapsed or refractory B-cell lymphomas in adults: follicular lymphoma, large B-cell lymphoma (LBCL), diffuse large B-cell lymphoma (DLBCL), and ...

In March 2019, Yescarta (axicabtagene ciloleucel) marked a significant advancement in the treatment of aggressive lymphomas, being one of the initial CAR T-cell therapies introduced. Diffuse Large ...

for relapsed or refractory diffuse large B-cell lymphoma; Welireg, for the treatment of treatment of von Hippel-Lindau (VHL) disease; and, Yescarta, for the treatment of follicular lymphoma, large ...